RxDoctor Payments Data

Alan Justice, MD

Internal Medicine · Macon, GANPI 1114955572

Payments from drug & device makers

$11,648in general payments, 2019–2025

Across 737 payments — averaging $15.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • AstraZeneca$1K
  • Astellas Pharma US Inc$964
  • Pfizer$870
  • Amgen$777
  • AbbVie$725
  • plus $6K from 53 others

What the payments were for

  • Food & beverage$11,25497%
  • Education$3813%
  • Entertainment$130%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk94$1,116
AstraZeneca67$1,018
Astellas Pharma US Inc39$964
Pfizer57$870
Amgen(2 entities)49$777
AbbVie(2 entities)51$725
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC32$537
Boehringer Ingelheim34$481
Sanofi-aventis U.S. LLC25$445
Novartis29$432
Esperion Therapeutics, Inc.21$355
Lilly USA, LLC23$353
Amarin Pharma, Inc.22$323
Otsuka America Pharmaceutical, Inc.15$308
Shield Therapeutics Inc12$279
Supernus Pharmaceuticals, Inc.16$206
Dexcom, Inc.11$195
Johnson & Johnson13$188
Merck12$186
GSK11$167
Bausch Health US, LLC8$148
Kowa Pharmaceuticals America, Inc.10$138
Biohaven Pharmaceuticals, Inc.9$129
Bayer5$96
Eisai Inc.5$87
Biohaven Pharmaceutical Holding Company Ltd.5$86
Lundbeck LLC4$85
Sumitomo Pharma America, Inc.4$68
Aytu Biopharma, Inc.5$65
Acadia Pharmaceuticals Inc3$51
Genentech USA, Inc.3$48
Idorsia Pharmaceuticals US Inc3$48
Amneal Pharmaceuticals LLC3$47
Abbott3$45
Boston Scientific2$45
E.r. Squibb & Sons, L.L.C.3$42
Corcept Therapeutics2$39
Xeris Pharmaceuticals, Inc.2$37
Hikma Pharmaceuticals USA2$36
Corium, LLC1$33
Edwards Lifesciences1$31
Ardelyx, Inc.2$31
Exact Sciences2$26
Actelion Pharmaceuticals US, Inc.1$24
BD1$22
Medicure Pharma Inc.1$20
Ironwood Pharmaceuticals, Inc1$20
Mannkind Corporation1$18
Medline Industries LP1$17
Eyevance Pharmaceuticals LLC1$17
Endo Pharmaceuticals Inc.1$17
Phathom Pharmaceuticals, Inc.1$15
Linus Health, Inc.1$15
Medtronic1$14
Takeda Pharmaceuticals U.S.A., Inc.1$14
Optos, Inc.1$13
Alfasigma USA, Inc.1$12
Clarus Therapeutics Inc.2$11
Metuchen Pharmaceuticals1$11

How this compares

$11,648 in reported general payments places this provider in the 90th percentile of 3,311 internal medicine providers in Georgia.

See all internal medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$1,702,662
Medicare patients
1,402
Services billed
121,230

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban311$283,835
JanuviaSitagliptin Phosphate224$250,638
OzempicSemaglutide151$219,400
JardianceEmpagliflozin145$171,307
TrulicityDulaglutide116$158,251
MounjaroTirzepatide120$147,486
FarxigaDapagliflozin Propanediol126$126,973
XareltoRivaroxaban174$112,830
MyrbetriqMirabegron125$80,727
LinzessLinaclotide83$60,499
Tresiba Flextouch U-100Insulin Degludec69$58,968
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog64$48,448
VascepaIcosapent Ethyl67$46,292
TradjentaLinagliptin104$45,921
RybelsusSemaglutide42$43,905

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
MerckJanuvia, Janumet, Janumet Xr$186$318,564286 claims
Lilly USA, LLCTrulicity, Mounjaro$353$305,736236 claims
PfizerEliquis$870$283,835311 claims
Novo NordiskOzempic, Rybelsus$1,116$263,304193 claims
Boehringer IngelheimJardiance, Tradjenta, Combivent Respimat, Stiolto Respimat$481$234,173281 claims
AstraZenecaFarxiga, Breztri Aerosphere$1,018$136,546139 claims
Johnson & JohnsonXarelto, Invokana$188$130,936192 claims
Astellas Pharma US IncMyrbetriq$964$80,727125 claims
AbbVieLinzess, Synthroid$725$70,726305 claims
NovartisEntresto$432$36,11939 claims
GSKTrelegy Ellipta$167$28,99024 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$47$12,0081,174 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,311 internal medicine providers in Georgia.

Other internal medicine in Macon

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →